Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

The Quality Lowdown: Alvotech, Lupin, Cipla, Lilly, Rentschler Inspection Findings And Akorn Recall

The Quality Lowdown

Related Content

Why Data Integrity Concerns Led Fresenius To Back Away From Akorn Deal

May 14 2018

The Quality Lowdown: Key Inspection Findings At Glenmark, Centrient, Lupin, Aurobindo, Mac-Chem

Dec 15 2022

FDA Warning Letter Hits Akorn’s Subpar Root Cause Investigations

Jul 10 2019

US FDA Warns Lupin Again About Poor Batch Failure Investigations

Oct 03 2019

Keeping Track: After COVID Delays, US FDA Approvals At Last For Daxxify, Rolvedon (But A CRL For Alvotech)

Sep 09 2022

FDA Cites Lupin For Poor Quality Metric Performance

Jun 30 2017

Related Companies

Alvotech

AbbVie Inc.

Lupin Limited

Cipla Limited

Eli Lilly and Company

Rentschler Biopharma SE

Apotex Inc.

Additional Topics

United States Manufacturing Quality Enforcement Compliance BioPharmaceutical

More from Manufacturing

More from Compliance

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window